Fingerprint
Dive into the research topics of 'Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies
M. L. Tetef, T. W. Synold, W. Chow, L. Leong, K. Margolin, R. Morgan, J. Raschko, S. Shibata, G. Somlo, Y. Yen, S. Groshen, K. Johnson, H. J. Lenz, D. Gandara, J. H. Doroshow
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations